The beneficial effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on cardiovascular
disease have been studied extensively. However, it remains unclear to what extent n-3 …

Atherosclerosis, the primary cause of cardiovascular disease (CVD), is a chronic
inflammatory disorder in the walls of medium and large arteries. CVD is currently …

Hypercholesterolaemia is a major risk factor for cardiovascular disease and it has been
found that some probiotic bacteria possess cholesterol-lowering capabilities. In this study …

Purpose Cardiovascular disease (CVD) is the leading cause of death, globally, and its
prevalence is only expected to rise due to the increasing incidence of co-morbidities such as …

Atherosclerosis (AS) is a chronic disease of the arterial wall where both innate and adaptive
immunoinflammatory mechanisms are involved. Inflammation plays an important role in the …

Atherosclerosis and its complications are responsible for one in three global deaths.
Nutraceuticals show promise in the prevention and treatment of atherosclerosis but require …

Scope Previous studies show that Lab4 probiotic consortium plus Lactobacillus plantarum
CUL66 (Lab4P) reduces diet‐induced weight gain and plasma cholesterol levels in …

Several diseases, including atherosclerosis, are characterized by inflammation, which is
initiated by leukocyte migration to the inflamed lesion. Hence, genes implicated in the early …

Background: Atherosclerosis (AS), a major risk factor for stroke and brain tissue destruction,
is an inflammatory disease of the blood vessels, and the underlying pathology is …

Atherosclerosis, an inflammatory disorder of the vasculature and the underlying cause of
cardiovascular disease, is responsible for one in three global deaths. Consumption of active …